Smith, Nikaïa http://orcid.org/0000-0002-0202-612X
Possémé, Céline
Bondet, Vincent http://orcid.org/0000-0002-6534-0984
Sugrue, Jamie http://orcid.org/0000-0001-7270-3838
Townsend, Liam http://orcid.org/0000-0002-7089-0665
Charbit, Bruno http://orcid.org/0000-0002-5478-482X
Rouilly, Vincent
Saint-André, Violaine
Dott, Tom
Pozo, Andre Rodriguez
Yatim, Nader
Schwartz, Olivier http://orcid.org/0000-0002-0729-1475
Cervantes-Gonzalez, Minerva
Ghosn, Jade
Bastard, Paul
Casanova, Jean Laurent
Szwebel, Tali-Anne
Terrier, Benjamin
Conlon, Niall
O’Farrelly, Cliona http://orcid.org/0000-0002-0616-2874
Cheallaigh, Clíona Ní
Bourke, Nollaig M. http://orcid.org/0000-0003-4313-6859
Duffy, Darragh http://orcid.org/0000-0002-8875-2308
Funding for this research was provided by:
Institut Pasteur (URGENCE COVID-19)
Agence Nationale de la Recherche (ANR-flash COVID-19, ANR-10-LABX-69-01)
Article History
Received: 28 May 2022
Accepted: 9 November 2022
First Online: 25 November 2022
Competing interests
: J.L.C. is an inventor on patent application PCT/US2021/042741, filed 22 July 2021, submitted by The Rockefeller University, which covers diagnosis of, susceptibility to, and treatment of viral disease and viral vaccines, including COVID-19 and vaccine-associated diseases. O.S. is an inventor on provisional patent no. US 63/020,063 entitled “S-Flow: a FACS-based assay for serological analysis of SARS-CoV2 infection” submitted by Institut Pasteur. The other authors declare no competing interests.
: Researchers involved in identification, recruitment, and sampling of patients in the clinical centers in Ireland and France have been included as co-authors.